IFP Advisors, Inc - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 104 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$3
-100.0%
18
-80.6%
0.00%
Q3 2022$6,000
-14.3%
93
-48.0%
0.00%
Q2 2022$7,0000.0%1790.0%0.00%
Q1 2022$7,000
-75.0%
179
-87.3%
0.00%
-100.0%
Q4 2018$28,000
+3.7%
1,4100.0%0.00%
+100.0%
Q3 2018$27,000
+35.0%
1,410
+7.6%
0.00%0.0%
Q2 2018$20,000
+233.3%
1,310
+322.6%
0.00%
Q1 2018$6,0000.0%3100.0%0.00%
Q4 2017$6,000
-78.6%
310
-80.1%
0.00%
-100.0%
Q3 2017$28,0001,5600.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2017
NameSharesValueWeighting ↓
MQS Management LLC 10,935$255,0000.41%
GLOBEFLEX CAPITAL L P 144,692$3,370,0000.34%
CORNERCAP INVESTMENT COUNSEL INC 58,975$1,374,0000.20%
Factorial Partners, LLC 10,900$254,0000.17%
FEDERATED HERMES, INC. 3,464,335$80,684,0000.15%
Campbell & CO Investment Adviser LLC 14,800$345,0000.12%
FULLER & THALER ASSET MANAGEMENT, INC. 611,462$14,241,0000.08%
Summit Global Investments 45,900$1,069,0000.07%
RENAISSANCE GROUP LLC 63,559$1,480,0000.06%
PDT Partners, LLC 33,459$779,0000.06%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders